CYP11B2 Gene Hypoaldosteronism congenital due to CMO I deficiency Genetic Test
Test Name:
CYP11B2 Gene Hypoaldosteronism congenital due to CMO I deficiency Genetic Test
Components:
Price: 4400.0 AED
Sample Condition:
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery:
3 to 4 Weeks
Method:
NGS Technology
Test Type:
Metabolic Disorders
Doctor:
General Physician
Test Department:
Genetics
Pre Test Information:
Clinical History of Patient who is going for CYP11B2 Gene Hypoaldosteronism congenital due to CMO I deficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hypoaldosteronism congenital due to CMO I deficiency
Test Details:
CYP11B2 gene hypoaldosteronism congenital due to CMO I deficiency is a genetic disorder that affects the production of aldosterone, a hormone involved in regulating salt and water balance in the body. This condition is caused by mutations in the CYP11B2 gene, which provides instructions for making an enzyme called aldosterone synthase. NGS (Next-Generation Sequencing) genetic testing is a method used to identify genetic mutations or variations in an individual’s DNA. It allows for the simultaneous analysis of multiple genes or even the entire genome, providing a comprehensive view of an individual’s genetic makeup. In the case of CYP11B2 gene hypoaldosteronism congenital due to CMO I deficiency, NGS genetic testing can be used to identify mutations or variations in the CYP11B2 gene that may be responsible for the condition. This can help with diagnosis, genetic counseling, and potentially guide treatment decisions. It is important to consult with a healthcare professional or genetic counselor to discuss the benefits, limitations, and implications of genetic testing for this condition. They can provide further information and guidance on how to proceed with testing and any potential implications for the individual and their family.
Test Name | CYP11B2 Gene Hypoaldosteronism congenital due to CMO I deficiency Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CYP11B2 Gene Hypoaldosteronism congenital due to CMO I deficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hypoaldosteronism congenital due to CMO I deficiency |
Test Details |
CYP11B2 gene hypoaldosteronism congenital due to CMO I deficiency is a genetic disorder that affects the production of aldosterone, a hormone involved in regulating salt and water balance in the body. This condition is caused by mutations in the CYP11B2 gene, which provides instructions for making an enzyme called aldosterone synthase. NGS (Next-Generation Sequencing) genetic testing is a method used to identify genetic mutations or variations in an individual’s DNA. It allows for the simultaneous analysis of multiple genes or even the entire genome, providing a comprehensive view of an individual’s genetic makeup. In the case of CYP11B2 gene hypoaldosteronism congenital due to CMO I deficiency, NGS genetic testing can be used to identify mutations or variations in the CYP11B2 gene that may be responsible for the condition. This can help with diagnosis, genetic counseling, and potentially guide treatment decisions. It is important to consult with a healthcare professional or genetic counselor to discuss the benefits, limitations, and implications of genetic testing for this condition. They can provide further information and guidance on how to proceed with testing and any potential implications for the individual and their family. |